Gene Query: DUSP5

Dataset Description Geneva Score
Crizotinib v. DMSO in SW480 cells 210.03
Role of COP1 on MAP kinase transcriptional output in melanoma 200.84
RNA-seq of young and quiescent MRC-5 human fibroblasts 121.61
SUV420H2 knockdown in PANC-1 110.73
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 104.33
Gene expression in PANC1 cells treated with Rakicidin 104.22
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 98.69
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 91.59
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 85.82
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 81.46
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 81.35
HNRNPM-regulated splicing dependencies in prostate cancer 81.35
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 81.26
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 81.14
Role of CD133 molecule in WNT response and renal repair 76.36
Effect of BB608 on Gene Expression in HNSCC Cell Line 73.25
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 72.86
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 70.13
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 68.18
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 66.77
Statins modulate endothelial transcriptional profile by inhibiting EZH2 66.65
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 65.66
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 65.23
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 64.99
BAF controls genome accessibility 64.07
RNA sequencing of GlyH-101-treated MCF-7 cell line 62.68
G-quadruplex structures mark human regulatory chromatin 61.4
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 61.32
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 60.77
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 60.6
Transcriptome analysis in Neobractatin treated cells 59.06
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 58.73
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 58.66
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 58.51
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 57.17
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 57.12
HNF1 regulates critical functions of the human epididymis epithelium. 56.83
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 56.83
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 54.65
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 51.92
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 49.98
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 49.15
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 48.97
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 48.2
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 48.19
Illumina Total RNA-seq in HeLa 47.59
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 47.03
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 46.7
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 46.15
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 45.92
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 45.9
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 45.9
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 45.8
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 45.79
Primary Human B-cell Temporal Response to CD40L Stimulation 45.77
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 45.22
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 45.19
Transcriptome analysis of U87 cells upon LINC00152 knockdown 44.99
Gene expression changes associated with resistance to tagraxofusp (SL-401) 44.66
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 44.6
Gene expression analysis of immortalized human liver progenitor-like cells in culture 44.22
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 44.18
Regulation of protein translation during mitosis 44.12
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 43.73
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 43.0
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 42.93
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 42.49
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 41.39
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 41.3
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 40.98
ARID1A regulates condensin II distribution and chromosomal partition 40.72
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 40.72
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 40.59
UBC9 knockdown in bladder cancer T24 cell lines 40.54
Identifying the molecular mode of action of itraconazole in colorectal cancer 40.28
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 39.92
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 39.85
The role of FAM46C in myeloma cells [sequencing] 39.64
The role of FAM46C in myeloma cells 39.64
TGF-β promotes genomic instability after loss of RUNX3 39.38
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 39.33
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 39.16
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 38.62
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 38.19
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 38.12
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 37.74
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 37.72
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 37.72
Gene Expression Profiling of SPOP Knocked Down Cell 36.77
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 36.53
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 36.51
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 36.5
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 36.07
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 35.91
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 35.87
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 35.43
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 35.43
oxLDL exposed trained monocytes 35.35
Transcriptomes of oxLDL exposed trained monocytes 35.35
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 35.3
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 35.3
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 35.24
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 35.16
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 34.79
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 34.7
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 34.54
Functional role of SLIT2 and ROBO1 in trophoblasts 34.06
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 33.67
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 33.51
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 33.51
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 33.34
Transcriptomic profiling of human peripheral blood-derived mast cells 33.16
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 33.16
RNA-seq of human aneuploid cell lines with Trisomy 21 33.15
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 33.11
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 32.72
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 32.67
Toxoplasma gondii infection of human retinal pigment epithelial cells 32.16
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 31.94
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 31.94
Effect of Influenza virus infection on lncRNA expression in A549 cells 31.71
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 31.66
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 31.65
FBXW7 modulates stress response by post-translational modification of HSF1 31.65
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 31.63
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 31.63
CD95/Fas ligand mRNA is toxic to cells 31.62
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 30.75
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 30.75
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 30.72
RNAseq Analysis in glioblastoma cells treated with Mepazine 30.72
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 30.25
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 30.25
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 30.15
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 30.08
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 30.03
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 30.03
MYCi361 regulates MYC target genes 30.02
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 29.95
ARID1A and ARID1B loss in HCT116 cells 29.93
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 29.3
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 29.11
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 29.11
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 28.69
4sUDRB-seq: measuring transcription elongation and initiation genomewide 28.48
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 28.43
The comparison of high-throughput single-cell RNA-seq methods 28.24
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 28.21
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 28.2
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 27.94
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 27.88
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 27.88
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 27.42
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 27.37
RNA sequencing of BT142 and TS603 cell lines 27.37
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 27.26
Genome-wide analysis of Dengue virus 2 infected cells 27.22
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 27.15
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 27.09
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 27.09
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 27.08
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 26.8
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 26.8
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 26.73
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 26.63
Effects of rFVIIIFc on human macrophages 26.63
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 26.4
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 26.25
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 26.23
Endometrial transcriptome and PGR cistrome in cycling fertile women 26.13
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 26.13
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 26.11
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 26.11
Aneuploidy triggers an immune response 25.95
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 25.89
naive T cell heterogeneity after neonatal thymectomy 25.87
Gene expression changes upon drug withdrawal (Mel888 cell line) 25.81
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 25.56
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 25.55
Mechanistic Model-Guided Study of Embryonic Morphogenesis 25.44
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 25.38
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 25.38
Genome-wide analysis of the Integrator complex (HTS) 25.08
Genome-wide analysis of the Integrator complex 25.08
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 25.02
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 25.01
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 24.98
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 24.9
Tpl-2 small molecule project 24.88
Tpl-2 and MEK small molecule inhibitors 24.88
Genetic-to-epigenetic Therapy for Pancreatic Cancer 24.83
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 24.76
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 24.61
Irf9 function in immunity in mouse 24.61
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 24.59
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 24.59
Polarized B -cell functions 24.36
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 24.24
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 24.2
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 24.14
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 24.14
PGE2 mediated gene expression changes in human cervical stromal cells 24.03
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 23.86
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 23.86
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 23.8
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 23.73
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 23.64
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 23.61
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 23.61
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 23.44
NAPRT activation of macrophages 23.39
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 23.21
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 23.18
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 23.05
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 23.01
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 23.01
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 22.93
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 22.68
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 22.49
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 22.45
Generation and functional characterization of MDSC-like cells 22.37
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 22.26
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 22.26
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 22.25
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 22.24
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 22.12
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 22.1
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 22.08
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 22.03
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 22.01
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 21.94
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 21.94
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 21.66
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 21.57
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 21.5
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 21.17
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 21.17
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 21.11
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 20.9
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 20.78
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 20.7
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 20.7
MYCi975 regulates MYC target genes 20.69
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 20.62
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 20.46
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 20.44
Androgen Receptor-regulated genes in prostate cancer cells 20.4
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 20.4
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 20.32
Overexpression and knockdown experiment for circCSNK1G3 20.3
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 20.22
Global analyses of the effect of different cellular contexts on microRNA targeting 20.22
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 20.21
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 20.13
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 20.13
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 20.09
Proliferation-correlated expression 19.91
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 19.74
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 19.74
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 19.72
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 19.72
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 19.54
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 19.53
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 19.45
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 19.39
Genome-wide transcriptional response to random aneuploidy in human cells 19.39
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 19.01
Identification of long noncoding RNAs regulated by p53 18.99
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 18.88
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 18.74
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 18.65
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 18.63
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 18.62
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 18.53
Nrf2 regulated genes in A549 cells 18.44
Identification of Nrf2 regulated genes by RNA sequencing 18.44
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 18.41
Regulating Interleukin-2 activity with engineered receptor signaling clamps 18.29
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 18.19
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 18.16
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 18.11
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 18.08
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 18.08
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 18.07
A single cell reference map for human blood and tissue T cell activation 17.93
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 17.9
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 17.88
snRNAs as regulators of alternative splicing 17.77
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 17.76
Silencing p300 in MCF7 cells to study expression and alternative splicing 17.67
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 17.62
RNA-seq analysis upon ARID1B overexpression 17.61
Expression data from miR340 overexpressing human A549 cells 17.58
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 17.57
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 17.55
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 17.51
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 17.42
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 17.11
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 17.11
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 16.87
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 16.79
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 16.76
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 16.75
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 16.75
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 16.74
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 16.69
Random mono-allelic expression in MECP2-mutated cells 16.53
Transcriptomes of human monocytes after ex vivo exposure to uric acid 16.53
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 16.47
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 16.46
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 16.34
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 16.19
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 16.19
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 16.18
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 16.09
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 16.09
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 16.03
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 16.03
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 15.88
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 15.88
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 15.87
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 15.76
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 15.69
Integrin signaling regulates YAP/TAZ to control skin homeostasis 15.67
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 15.62
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 15.55
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 15.51
Genome-wide chromatin analysis of Ewing sarcoma 15.34
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 15.34
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 15.05
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 15.03
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 14.95
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 14.95
JunB control of keratinocyte-mediated inflammation [RNA-seq] 14.91
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 14.91
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 14.81
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 14.77
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 14.67
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 14.63
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 14.62
Gene Expression Profiling of WT and KDM3A Knocked out Cell 14.6
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 14.6
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 14.5
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 14.44
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 14.3
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 14.25
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 14.24
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 14.23
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 14.14
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 13.95
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 13.93
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 13.93
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 13.7
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 13.6
MARCKS and lnc-MARCKS act as inflammation regulators 13.52
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 13.41
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 13.37
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 13.37
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 13.35
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 13.16
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 13.1
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 13.09
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 13.08
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 13.05
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 12.95
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 12.71
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 12.6
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 12.6
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 12.53
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 12.35
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 12.29
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 12.27
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 12.15
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 12.15
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 12.1
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 11.98
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 11.98
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 11.92
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 11.72
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 11.63
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 11.63
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 11.59
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 11.57
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 11.53
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 11.29
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 11.22
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 11.2
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 11.2
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 11.0
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 10.87
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 10.84
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 10.76
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 10.69
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 10.6
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 10.5
RNA-Seq in neutrophils from Antiphospholipid Syndrome 10.31
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 10.3
Total RNA-Seq data from leukemic patients with complex structural variants 10.25
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 10.19
Regulation of hypoxia-inducible factor activity by ZMYND8 10.12
ADAR1-editing of cellular and measles virus-derived duplex RNA 9.98
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 9.98
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 9.91
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 9.91
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 9.87
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 9.86
BET bromodomain inhibition 9.86
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 9.47
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 9.47
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 9.34
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 9.3
Be1 and Be2 B cells are transcriptionally distinct 9.11
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 9.04
RNA seq with AML (NB4) cells upon FTO inhibition 8.89
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 8.85
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 8.82
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 8.77
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 8.39
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 8.39
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 8.29
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 8.29
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 8.24
An optimization system for isolating and sequencing of single human colon cancer cells 8.09
JAK dependent survival of ALK- ALCL 8.0
MAIT cell RNA sequencing 7.5
Selective expression of long non-coding RNAs in a breast cancer cell progression model 7.35
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 7.13
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 6.49
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 6.39
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 6.25
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 6.16
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 6.16
CD86 regulates a pro-survival signal in myeloma cells 6.16
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 6.06
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 5.86
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 5.66
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 5.37
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 5.36
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 5.17
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 5.09
Nonpregnant and term pregnant human myometrial tissues 5.09
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 4.94
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 4.88
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 4.6
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 4.6
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 4.43
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 4.34
Zika virus infection reprograms global transcription of host cells to allow sustained infection 4.31
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 4.23
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 4.23
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 4.2
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 4.12
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 4.06
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 4.03
Differential gene expression of human melanoma cells [RNA-seq] 4.03
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 3.84
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 3.84
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 3.82
KSDM1b Role in Ewing Sarcoma 3.71
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 3.6
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 3.52
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 3.52
Gene expression changes due to PARP knockdown in human cells 3.47
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 3.4
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 3.31
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 3.31
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 3.23
DRB/GRO-Seq -/+ UV 3.04
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 3.02
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 3.01
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 2.93
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 2.86
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 2.85
MRTF activates TEAD-YAP target gene expression 2.81
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 2.65
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 2.59
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 2.41
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 2.37
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 2.28
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 2.1
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 1.79
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 1.78
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 1.78
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 1.72
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 1.68
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 1.57
Transcriptomic analysis of human macrophages in 3D 1.17
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 1.16
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 1.08
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 1.07
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.96
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.91
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 0.89
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.68
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 0.62
6mer seed toxicity in viral microRNAs 0.4
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 0.19
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.15
Gene expression profile of CRC-derived HILEC 0.12
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation